Yakup Ergün (Yakup Ergun)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 23

Top Topics

Locally Advanced

Neoadjuvant Chemotherapy

Prognostic Factors

Top Venues

Future oncology (London, England)

Expert opinion on pharmacotherapy

Medical oncology (Northwood, London, England)

JCO oncology practice

This page only lists publications with an associated author ORCID identifier.

Publications

Yusuf Ilhan, Gokhan Ucar, Mehmet Nuri Baser, Halil Goksel Guzel, Safa Can Efil, Bilgin Demir, Duygu Ercan Uzundal, Tuba Karacelik, Nadiye Sever, Onur Yazdan Balcik, Hayati Arvas, Ibrahim Karadag, Ahmet Kadioglu, Ömer Burak Ekinci, Cengiz Karacin, Zuhat Urakci, Osman Kostek, Melek Karakurt Eryilmaz, Ozan Yazici, Mehmet Ali Nahit Sendur, Banu Ozturk, Dogan Uncu, Yakup Ergün
Efficacy and safety of G-CSF prophylaxis in patients with extensive-stage small cell lung cancer receiving chemoimmunotherapy. Expert opinion on pharmacotherapy 25 (11) (2024)
Yusuf Ilhan, Gokhan Ucar, Mehmet Nuri Baser, Halil Goksel Guzel, Safa Can Efil, Bilgin Demir, Duygu Ercan Uzundal, Tuba Karaceli K, Nadiye Sever, Onur Yazdan Balcik, Hayati Arvas, Ibrahim Karadag, Ahmet Kadioglu, Ömer Burak Ekinci, Cengiz Karacin, Zuhat Urakci, Osman Kostek, Melek Karakurt Eryilmaz, Ozan Yazici, Mehmet Ali Nahit Sendur, Banu Ozturk, Dogan Uncu, Yakup Ergün
Efficacy and safety of G-CSF prophylaxis in patients with extensive-stage small cell lung cancer receiving Chemoimmunotherapy. Expert opinion on pharmacotherapy (2024)
Yasin Kutlu, Shute Ailia Dae, Feride Yilmaz, Dilek Erdem, Mehmet Ali Nahit Sendur, Sinem Akbas, Elif Senocak Tasci, Onur Bas, Faysal Dane, Abdullah Sakin, Ali Osman Kaya, Musa Baris Aykan, Yakup Ergün, Sedat Biter, Umut Disel, Mustafa Korkmaz, Fatih Selcukbiricik, Fatih Kose, Omer Fatih Olmez, Ahmet Bilici, Gokhan Demir, Suayib Yalcin
Real-World Efficacy and Safety of First-Line Nivolumab Plus Chemotherapy in Patients with Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: A Nationwide Observational Turkish Oncology Group (TOG) Study. Cancers 16 (12) (2024)
Cengiz Karaçin, Veli Sunar, Zuhat Urakci, Ali Yilmaz, Murat Ayhan, Mustafa Ersoy, Deniz Can Guven, Ismail Erturk, Yasin Durmus, Pinar Karacin, Nurettin Boran, Yaprak Engin Ustun, Mutlu Meydan, Mutlu Doğan, Berna Oksuzoğlu, Ozturk Ates, Mustafa Karaca, Dogan Uncu, Yakup Ergün, Zafer Arik
Efficacy and safety of bevacizumab in patients with low-grade serous ovarian cancer. Future oncology (London, England) 20 (4) (2024)
Cengiz Karaçin, Veli Sunar, Zuhat Urakci, Ali Yilmaz, Murat Ayhan, Mustafa Ersoy, Deniz Can Guven, Ismail Erturk, Yasin Durmus, Pinar Karacin, Nurettin Boran, Yaprak Engin Ustun, Mutlu Meydan, Mutlu Doğan, Berna Oksuzoğlu, Ozturk Ates, Mustafa Karaca, Dogan Uncu, Yakup Ergün, Zafer Arik
Efficacy and safety of bevacizumab in patients with low-grade serous ovarian cancer. Future oncology (London, England) (2024)
Cengiz Karaçin, Veli Sunar, Zuhat Urakci, Ali Yilmaz, Murat Ayhan, Mustafa Ersoy, Deniz Can Guven, Ismail Erturk, Yasin Durmus, Pinar Karacin, Nurettin Boran, Yaprak Engin Ustun, Mutlu Meydan, Mutlu Doğan, Berna Oksuzoğlu, Ozturk Ates, Mustafa Karaca, Dogan Uncu, Yakup Ergün, Zafer Arik
Efficacy and safety of bevacizumab in patients with low-grade serous ovarian cancer. Future oncology (London, England) 20 (4) (2024)
Yasin Kutlu, Shute Ailia Dae, Feride Yilmaz, Dilek Erdem, Mehmet Ali Nahit Sendur, Sinem Akbas, Elif Senocak Tasci, Onur Bas, Faysal Dane, Abdullah Sakin, Ali Osman Kaya, Musa Baris Aykan, Yakup Ergün, Sedat Biter, Umut Disel, Mustafa Korkmaz, Fatih Selcukbiricik, Fatih Kose, Omer Fatih Olmez, Ahmet Bilici, Gokhan Demir, Suayib Yalcin
Real-World Efficacy and Safety of First-Line Nivolumab Plus Chemotherapy in Patients with Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: A Nationwide Observational Turkish Oncology Group (TOG) Study. Cancers 16 (12) (2024)
Yusuf Ilhan, Gokhan Ucar, Mehmet Nuri Baser, Halil Goksel Guzel, Safa Can Efil, Bilgin Demir, Duygu Ercan Uzundal, Tuba Karacelik, Nadiye Sever, Onur Yazdan Balcik, Hayati Arvas, Ibrahim Karadag, Ahmet Kadioglu, Ömer Burak Ekinci, Cengiz Karacin, Zuhat Urakci, Osman Kostek, Melek Karakurt Eryilmaz, Ozan Yazici, Mehmet Ali Nahit Sendur, Banu Ozturk, Dogan Uncu, Yakup Ergün
Efficacy and safety of G-CSF prophylaxis in patients with extensive-stage small cell lung cancer receiving chemoimmunotherapy. Expert opinion on pharmacotherapy (2024)
Eda Caliskan Yildirim, Yusuf Acikgoz, Yakup Ergün, Efnan Algin, Oznur Bal
Treatment Outcomes and Prognostic Factors in N3 Stage Gastric Cancer After Curative Resection: A Real World Data. Cancer management and research 15 (2023)
Yakup Ergün, Mutlu Dogan, Gokhan Ucar, Pınar Karacin, Cengiz Karacin
Efficacy of adjuvant CDK4/6 inhibitors in Hormone Receptor-positive breast cancer: a systematic review and meta-analysis. Expert opinion on pharmacotherapy (2023)
Yakup Ergün, Gokhan Ucar, Baran Akagunduz
Efficacy and safety of concomitant chemo-endocrine therapy in neoadjuvant treatment of hormone-positive HER2-negative breast cancer: a systemic review and meta-analysis. Expert opinion on drug safety (2023)
Yakup Ergün
Significance of Confounding Factors in Retrospective Observational Studies. JCO oncology practice (2023)
Cengiz Karaçin, Yakup Ergün, Ömür Berna Çakmak Öksüzoğlu
Saying goodbye to primary endocrine resistance for advanced breast cancer? Medical oncology (Northwood, London, England) 38 (1) (2021)
Yusuf Acikgoz, Öznur Bal, Gokhan Ucar, Ayse Durnali, Yakup Ergün, Merve Dirikoc, Selin Akturk Esen, Mutlu Doğan
Is there any clinical or laboratory predictive factor for cetuximab-induced skin toxicity? Expert opinion on drug safety 20 (5) (2021)
Mustafa Gürbüz, Erman Akkuş, Abdullah Sakin, Semiha Urvay, Atike Gökçen Demiray, Suleyman Sahin, Teoman Sakalar, Cihan Erol, Mehmet Ali Nahit Şendur, Ahmet Bilgehan Şahin, Erdem Cubukcu, Deniz Can Guven, Saadettin Kılıçkap, Yakup Ergün, Doğan Uncu, Nazım Serdar Turhal, Necdet Üskent, Havva Yeşil Çinkir, Atakan Demir, Ramazan Acar, Nuri Karadurmus, Sema Türker, Mustafa Altınbaş, Mert Karaoğlan, Filiz Çay Şenler
Trastuzumab ± Capecitabine Maintenance After the First-Line Treatment of HER2-Positive Advanced Gastric Cancer: Retrospective Observational Real-Life Data of Turkish Oncology Group. Journal of gastrointestinal cancer (2021)
Yakup Ergün, Selin Akturk Esen, Gokhan Ucar, Yusuf Acikgoz, Cengiz Karaçin
Is It Safe to Use Long-Acting G-CSF for Febrile Neutropenia Prophylaxis in COVID-19 Pandemic? JCO oncology practice 17 (7) (2021)
Cengiz Karaçin, Tulay Eren, Esra Zeynelgil, Goksen İnanc İmamoglu, Mustafa Altınbaş, Ibrahim Karadag, Fatma Bugdayci Basal, Hasan Selçuk Özger, Osman Sütçüoğlu, Ozan Yazıcı, Nuriye Ozdemir, Ahmet Özet, Yeşim Yıldız, Selin Aktürk Esen, Gokhan Ucar, Doğan Uncu, Bedia Dinc, Musa Baris Aykan, İsmail Ertürk, Nuri Karadurmus, Burak Civelek, İsmail Çelik, Yakup Ergün, Mutlu Doğan, Ömür Berna Çakmak Öksüzoğlu
Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy. Future oncology (London, England) 17 (33) (2021)
Cengiz Karaçin, Pinar Karacin, Yakup Ergün
Tamoxifen in breast cancer survivors with COVID 19: stop or go? Medical oncology (Northwood, London, England) 38 (4) (2021)
Mutlu Dogan, Servet Guresci, Yusuf Acikgoz, Yakup Ergün, Fahriye Tugba Kos, Onder Bozdogan, Öznur Bal
Is there any correlation among MKK4 (mitogen-activated protein kinase kinase 4) expression, clinicopathological features, and KRAS/NRAS mutation in colorectal cancer. Expert review of molecular diagnostics 20 (8) (2020)
Gokhan Ucar, Yakup Ergün, Yusuf Acikgoz, Doğan Uncu
The prognostic value of the prognostic nutritional index in patients with metastatic colorectal cancer. Asia-Pacific journal of clinical oncology 16 (5) (2020)
Ismail Beypinar, Hacer Demir, Abdullah Sakin, Burcu Yapar Taşköylü, Teoman Sakalar, Yakup Ergün, Mustafa Korkmaz, Ozturk Ates, Tulay Eren, Nazım Serdar Turhal, Mustafa Yıldırım
The Real-Life Data of BRAF Mutation on the Treatment of Colorectal Cancer: a TOG Study. Journal of gastrointestinal cancer (2020)
Tulay Eren, Cengiz Karaçin, Gokhan Ucar, Yakup Ergün, Ozan Yazıcı, Goksen İnanc İmamoglu, Nuriye Ozdemir
Correlation between peripheral blood inflammatory indicators and pathologic complete response to neoadjuvant chemotherapy in locally advanced breast cancer patients. Medicine 99 (22) (2020)
Yakup Ergün, Yusuf Acikgoz, Öznur Bal, Gokhan Ucar, Merve Dirikoc, Eda Caliskan Yildirim, Nadiye Akdeniz, Doğan Uncu
KRAS codon 12 and 13 mutations may guide the selection of irinotecan or oxaliplatin in first-line treatment of metastatic colorectal cancer. Expert review of molecular diagnostics 19 (12) (2019)